Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.2550 (19.03%) ($7.2550 - $7.3050) on Mon. Dec. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.19% (three month average) | RSI | 81 | Latest Price | $7.2550(19.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 8.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 14.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKK(5%) XRT(5%) VIXM(4%) ARKG(3%) IBUY(3%) | Factors Impacting BCRX price | BCRX will decline at least -2.595% in a week (0% probabilities). XLP(-10%) XLV(-8%) XLK(-8%) VUG(-7%) UNG(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.595% (StdDev 5.19%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.67(27.95%) | 10 Day Moving Average | $5.28(37.41%) | 20 Day Moving Average | $4.79(51.46%) | To recent high | 0% | To recent low | 44.1% | Market Cap | $1.28b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |